Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 6036-6047

  Robbins, Paul F ^a   El Gamil, Mona ^a   Li, Yong F ^a   Zeng, Gang ^a   Dudley, Mark ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GENE PRODUCT; GLYCOPROTEIN GP 100; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; TUMOR ANTIGEN; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2;

ADOPTIVE TRANSFER; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; AUTOTRANSPLANTATION; CELL DIFFERENTIATION; CELL INFILTRATION; CELL ISOLATION; CELL SPECIFICITY; CELL TRANSFER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCELE; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MELANOCYTE; MELANOMA; PRIORITY JOURNAL;

EID: 0037111530     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.6036     Document Type: Article

References (43)

1. Schwartzentruber, D. J., S. S. Hom, R. Dadmarz, D. E. White, J. R. Yannelli, S. M. Steinberg, S. A. Rosenberg, and S. L. Topalian. 1994, In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2. J. Clin. Oncol. 12:1475,
2. + T lymphocytes. J. Interferon Cytokine Res, 15:739.
3. Kawakami, Y., N. Dang, X. Wang, J. Tupesis. P. F. Robbins, R. F. Wang, J. R. Wunderlich. J. R. Yannelli, and S. A. Rosenberg. 2000. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. J. Immunother. 23:17.
4. Renkvist, N., C. Castelli, P. F. Robbins, and G. Parmiani. 2001. A listing of human tumor antigens recognized by T cells. Cancer Immunol. Immunother. 50:3.
5. Houghton, A. N., T. M. Thomson, D. Gross, H. F. Oettgen, and L. J. Old. 1984. Surface antigens of melanoma and melanocytes: Specificity of induction of la antigens by human γ-interferon. J. Exp. Med. 160:255.
6. Chiari, R., G. Hames, V. Stroobant, C. Texier, B. Maillere, T. Boon, and P. G. Coulie. 2000. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules. Cancer Res. 60:4855.
7. + T cells. J. Exp. Med. 189:757.
8. Wang, R. F., X. Wang, A. C. Atwood, S. L. Topalian, and S. A. Rosenberg. 1999. Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen. Science 284:1351.
9. + T cells. J. Exp. Med. 189: 1659.
10. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333: 1038.
11. Lu, Y., J. M. Boss, S. X. Hu, H. J. Xu, and G. Blanck. 1996. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-γ inducibility in non-small cell lung carcinoma cells: Lack of surface class II expression associated with a specific defect in HLA-DRA induction. J. Immunol. 156:2495.
12. Naviaux, R. K., E. Costanzi, M. Haas, and I. M. Verma. 1996. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701.
13. Player, M. A., K. C. Barracchini, T. B. Simonis, L. Rivoltini, F. Arienti, C. Castelli, A. Mazzocchi, F. Belli, G. Parrniani, and F. M. Marincola. 1996. Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: Relevance for epitope specific vaccination protocols. J. Immunother. Emphasis Tumor Immunol. 19:357.
14. Robbins, P. F., M. El-Gamil, Y. Kawakami, E. Stevens, J. Yannelli, and S. A. Rosenberg. 1994. Recognition of tyrosinase by tumor infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54:3124.
15. Robbins, P. F., M. El-Gamil, Y. F. Li, S. L. Topalian, L. Rivoltini, K. Sakaguchi, E. Appella, Y. Kawakami, and S. A. Rosenberg. 1995. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24 restricted tumor-infiltrating lymphocytes. J. Immunol. 154:5944.
16. Robbins, P. F., M. El-Gamil, Y. F. Li, Y. Kawakami, D. Loftus, E. Appella, and S. A. Rosenberg. 1996. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183: 1185.
17. Robbins, P. F., M. El-Gamil, Y. F. Li, E. B. Fitzgerald, Y. Kawakami, and S. A. Rosenberg. 1997. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J. Immunol. 159:303.
18. Chang, C. H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
19. + T lymphocytes against human melanoma: Evidence for a shared melanoma antigen presented by HLADR15. J. Immunol. 154:772.
20. Li, K., M. Adibzadeh, T. Halder, H. Kalbacher, S. Heinzel, C. Muller, J. Zeuthen, and G. Pawelec. 1998. Tumor-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells. Cancer Immunol. Immunother. 47:32.
21. Touloukian, C. E., W. W. Leitner, S. L. Topalian, Y. F. Li, P. F. Robbins, S. A. Rosenberg, and N. P. Restifo. 2000. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice. J. Immunol. 164: 3535.
22. Lapointe, R., R. E. Royal, M. E. Reeves, I. Altomare, P. F. Robbins, and P. Hwu. 2001. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MCH class I and class II epitopes from the melanoma antigen glycoprotein 100. J. Immunol. 167:4758.
23. + T cell epitopes from NY-ESO-I presented by HLA-DR molecules. J. Immunol. 165:1153.
24. + T lymphocytes of patients with NY-ESO-I-expressing melanoma. J. Exp. Med. 191:625.
25. + T cells. Cancer Res. 60:4946.
26. Xu, Y., V. Setaluri, Y. Takechi, and A. N. Houghton. 1997. Sorting and secretion of a melanosome membrane protein, gp75/TRPI. J. Invest. Dermatol. 109:788.
27. + T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med. 183: 1965.
28. Kobayashi, H., J. Lu, and E. Celis. 2001. Identification of helper T-cell epitopes that encompass or tie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen. Cancer Res. 61:7577.
29. + T cell responses. J. Immunol. 163:5820.
30. Calvo, P. A., D. W. Frank, B. M. Bieler, J. F. Berson, and M. S. Marks. 1999. A cytoplasmic sequence in human tyrosinase defines a second class of di-leucinebased sorting signals for late endosomal and lysosomal delivery. J. Biol. Chem. 274:12780.
31. + HLA class II-restricted T cell clones against a human sarcoma: Evidence for several recognized antigens. J. Immunol. 156:2205.
32. + T helper 2 cells: Requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells. Cell. Immunol. 210:96.
33. + T cells. Proc. Natl. Acad. Sci. USA 97:400.
34. Del Prete, G. F., M. De Carli. M. Ricci, and S. Romagnani. 1991. Helper activity for immunoglobulin synthesis of T helper type I (Th1) and Th2 human T cell clones: The help of th1 clones is limited by their cytolytic capacity. J. Exp. Med. 174:809.
35. + T cells. Virology 287:79.
36. Naftzger, C., Y. Takechi, H. Kohda, I. Hara, S. Vijayasaradhi, and A. N. Houghton. 1996. Immune response to a differentiation antigen induced by altered antigen: A study of tumor rejection and autoimmunity. Proc. Natl. Acad. Sci. USA 93:14809.
37. + T lymphocytes. Proc. Natl. Acad. Sci. USA 96:2982.
38. Hara, I., Y. Takechi. and A. N. Houghton, 1995. Implicating a role for immune recognition of self in tumor rejection: Passive immunization against the brown locus protein. J. Exp. Med. 182:1609.
39. Zeh, H. J., III, D. Perry-Lalley, M. E. Dudley. S. A. Rosenberg, and J. C. Yang. 1999. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J. Immunol. 162:989
40. Kawakami, Y., S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang, S. Southwood, P. F. Robbins, A. Sette. E. Appella, and S. A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154: 3961.
41. Hawkins, W. G., J. S. Gold, R. Dyall, J. D. Wolchok, A. Hoos, W. B. Bowne, R. Srinivasan, A. N. Houghton, and J. J. Lewis. 2000. Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity. Surgery 128:273.
42. Overwijk, W. W., A. Tsung, K. R. Irvine, M. R. Parkhurst, T. J. Goletz, K. Tsung, M. W. Carroll, C. Liu, B. Moss, S. A. Rosenberg, and N. P. Restifo. 1998. gp100/pmel 17 is a murine tumor rejection antigen: Induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J. Exp. Med. 188: 277.
43. +T cells. Br. J. Cancer 85:1738.